Literature DB >> 21900951

The dual effect of the lupus-associated polymorphism rs10516487 on BANK1 gene expression and protein localization.

S V Kozyrev1, M Bernal-Quirós, M E Alarcón-Riquelme, C Castillejo-López.   

Abstract

Numerous loci have been found genetically associated with complex diseases, but only in a few cases has the functional variant and the molecular mechanism behind it been identified. Recently, the association of the BANK1 gene with systemic lupus erythematosus (SLE) was described. Here, we investigated the role of the associated polymorphisms on gene function and found that SNP rs17266594 located in the branch point consensus sequence has negligible effect on splicing or gene expression. The non-synonymous SNP rs10516487 located in exon 2 influenced splicing efficiency by creating an exonic splicing enhancer site for the SRp40 factor. Further, this same SNP generates protein isoforms with differential and measurable self-association properties. The full-length protein isoform containing the R61 variant forms larger protein scaffold complexes in the cell cytoplasm compared with the protective BANK1-61H variant. We also observed that, contrary to the full-length isoforms, the short Δ2 isoform of BANK1 displays a homogeneous cytoplasmic distribution, underscoring the potential role of the exon 2-coded protein domain in the scaffolding function of BANK1. We provide evidence that the non-synonymous SNP rs10516487 (G>A; R61H) shows a dual nature by first, influencing mRNA splicing and consequently the quantity of protein, and, second, by producing a risk variant-containing protein isoform with increased potential for multimerization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900951      PMCID: PMC3291805          DOI: 10.1038/gene.2011.62

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  41 in total

Review 1.  Listening to silence and understanding nonsense: exonic mutations that affect splicing.

Authors:  Luca Cartegni; Shern L Chew; Adrian R Krainer
Journal:  Nat Rev Genet       Date:  2002-04       Impact factor: 53.242

2.  Isolation of proteins that interact with the signal transduction molecule Dof and identification of a functional domain conserved between Dof and vertebrate BCAP.

Authors:  Alysia Battersby; Agnes Csiszár; Maria Leptin; Robert Wilson
Journal:  J Mol Biol       Date:  2003-06-06       Impact factor: 5.469

3.  Aggregate formation and synaptic abnormality induced by DSCR1.

Authors:  Hong Ma; Hui Xiong; Tong Liu; Lingyan Zhang; Adam Godzik; Zhuohua Zhang
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

4.  A functional domain of Dof that is required for fibroblast growth factor signaling.

Authors:  Robert Wilson; Alysia Battersby; Agnes Csiszar; Elisabeth Vogelsang; Maria Leptin
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

5.  Pre-mRNA splicing by complementation with purified human U1, U2, U4/U6 and U5 snRNPs.

Authors:  A R Krainer
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

6.  Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.

Authors:  Luca Cartegni; Adrian R Krainer
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

7.  A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.

Authors:  Tsuyoshi Kashima; James L Manley
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

8.  ESEfinder: A web resource to identify exonic splicing enhancers.

Authors:  Luca Cartegni; Jinhua Wang; Zhengwei Zhu; Michael Q Zhang; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

Review 9.  Genomic variants in exons and introns: identifying the splicing spoilers.

Authors:  Franco Pagani; Francisco E Baralle
Journal:  Nat Rev Genet       Date:  2004-05       Impact factor: 53.242

10.  New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12.

Authors:  Franco Pagani; Cristiana Stuani; Maria Tzetis; Emmanuel Kanavakis; Alexandra Efthymiadou; Stavros Doudounakis; Teresa Casals; Francisco E Baralle
Journal:  Hum Mol Genet       Date:  2003-05-15       Impact factor: 6.150

View more
  20 in total

Review 1.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

Review 2.  Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective.

Authors:  Ali Javinani; Amir Ashraf-Ganjouei; Saeed Aslani; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Immunogenetics       Date:  2019-01-22       Impact factor: 2.846

3.  Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription.

Authors:  Joel M Guthridge; Rufei Lu; Harry Sun; Celi Sun; Graham B Wiley; Nicolas Dominguez; Susan R Macwana; Christopher J Lessard; Xana Kim-Howard; Beth L Cobb; Kenneth M Kaufman; Jennifer A Kelly; Carl D Langefeld; Adam J Adler; Isaac T W Harley; Joan T Merrill; Gary S Gilkeson; Diane L Kamen; Timothy B Niewold; Elizabeth E Brown; Jeffery C Edberg; Michelle A Petri; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vilá; Robert P Kimberly; Barry I Freedman; Anne M Stevens; Susan A Boackle; Lindsey A Criswell; Tim J Vyse; Timothy W Behrens; Chaim O Jacob; Marta E Alarcón-Riquelme; Kathy L Sivils; Jiyoung Choi; Young Bin Joo; So-Young Bang; Hye-Soon Lee; Sang-Cheol Bae; Nan Shen; Xiaoxia Qian; Betty P Tsao; R Hal Scofield; John B Harley; Carol F Webb; Edward K Wakeland; Judith A James; Swapan K Nath; Robert R Graham; Patrick M Gaffney
Journal:  Am J Hum Genet       Date:  2014-04-03       Impact factor: 11.025

4.  The BANK1 SLE-risk variants are associated with alterations in peripheral B cell signaling and development in humans.

Authors:  Elizabeth M Dam; Tania Habib; Janice Chen; Andrew Funk; Veronika Glukhova; Mel Davis-Pickett; Shan Wei; Richard James; Jane H Buckner; Karen Cerosaletti
Journal:  Clin Immunol       Date:  2016-11-02       Impact factor: 3.969

Review 5.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

6.  BANK1 controls CpG-induced IL-6 secretion via a p38 and MNK1/2/eIF4E translation initiation pathway.

Authors:  Ying-Yu Wu; Ramesh Kumar; Mohammed Shamsul Haque; Casimiro Castillejo-López; Marta E Alarcón-Riquelme
Journal:  J Immunol       Date:  2013-11-13       Impact factor: 5.422

7.  Genetic risk factors for sclerotic graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Paul J Martin; Mary E D Flowers; Stephanie J Lee; Paul A Carpenter; Edus H Warren; Daniel E Geraghty; Ni Lee; Michael J Boeckh; Barry E Storer; David M Levine; Wenhong Fan; Lue-Ping Zhao; John A Hansen
Journal:  Blood       Date:  2016-06-16       Impact factor: 22.113

Review 8.  The Role of BANK1 in B Cell Signaling and Disease.

Authors:  Gonzalo Gómez Hernández; María Morell; Marta E Alarcón-Riquelme
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

9.  Variants in BANK1 are associated with lupus nephritis of European ancestry.

Authors:  Karin Bolin; Juliana Imgenberg-Kreuz; Dag Leonard; Johanna K Sandling; Andrei Alexsson; Pascal Pucholt; Malena Loberg Haarhaus; Jonas Carlsson Almlöf; Joanne Nititham; Andreas Jönsen; Christopher Sjöwall; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Elisabet Svenungsson; Iva Gunnarsson; Ann-Christine Syvänen; Karoline Lerang; Anne Troldborg; Anne Voss; Øyvind Molberg; Søren Jacobsen; Lindsey Criswell; Lars Rönnblom; Gunnel Nordmark
Journal:  Genes Immun       Date:  2021-06-14       Impact factor: 2.676

10.  Epistatic interaction between BANK1 and BLK in rheumatoid arthritis: results from a large trans-ethnic meta-analysis.

Authors:  Emmanuelle Génin; Baptiste Coustet; Yannick Allanore; Ikue Ito; Maria Teruel; Arnaud Constantin; Thierry Schaeverbeke; Adeline Ruyssen-Witrand; Shigeto Tohma; Alain Cantagrel; Olivier Vittecoq; Thomas Barnetche; Xavier Le Loët; Patrice Fardellone; Hiroshi Furukawa; Olivier Meyer; Benjamin Fernández-Gutiérrez; Alejandro Balsa; Miguel A González-Gay; Gilles Chiocchia; Naoyuki Tsuchiya; Javier Martin; Philippe Dieudé
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.